1,3-Butadiene (BD) is an important industrial chemical and environmental contaminant, e.g. in urban air, traffic exhausts and tobacco smoke. It has been shown to be genotoxic in vitro and in vivo and carcinogenic in rodents, mice being more sensitive than rats. The present study confirmed this species difference. Using micronuclei in erythrocytes or bone marrow as a marker, mice responded at an effective level of 50 p.p.m., while the highest ineffective level in rats was 500 p.p.m. (inhalation of BD for 5 days). A dose-dependent increase in N-terminal valine haemoglobin adducts was seen in both rats and mice, but the adduct levels in the latter species were on average five times higher. For the first time, specific A^-alkyldeoxyadenosine adducts were identified in lung and liver DNA of rats exposed to BD by inhalation. No significant difference in DNA adduct level was seen in lung tissue of rats and mice at similar exposure levels. Occupational exposure levels to BD in the European Process industry are variable, but generally <1 p.p.m. Haemoglobin adduct levels were seen to be increased among the worker groups with higher potential exposure to BD (process work, bomb voiding and repair duties) as compared with adduct levels in less exposed workers in maintenance and the laboratory or control personnel. However, the A'-terminal valine haemoglobin adducts measured in the workers were one to two orders of magnitude lower than extrapolated for the same exposure dose in mice. In the same workers no exposurerelated effects were seen in the cytogenetic parametres studied, i.e. chromosomal aberrations, sister chromatid exchanges or micronuclei in peripheral blood lymphocytes, or in the Ras oncoprotein levels of plasma samples. The studies so far conducted suggest that human exposure at the levels seen in the present day process industry can be documented at the biological dose level using haemoglobin adduct measurement, but not at the biological effect level using cytogenetic biomarkers. In order to quantitate the human genotoxic risk of BD exposure more work needs to be done on the role of other active BD metabolites than l,2-epoxy-3-butene and on the genetic polymorphisms controlling the variability of individual responses.
Introduction 1,3-Butadiene (BD) is an important product of the petrochemical industry. Its annual production in the European Community was 1.8 million tonnes in 1991 (ECETOC, 1993) . BD is used principally as a monomer for producing a wide range of polymers and co-polymers, the largest single use being styrenebutadiene rubber for tyres and tyre products.
BD also occurs as an environmental contaminant. It has been estimated that most BD emissions derive from mobile sources, although leaks and waste emissions from manufacturing facilities may be locally important. All burning of organic material produces emissions containing minor amounts of BD. Tobacco smoke contains small amounts of BD; one cigarette produces 0.3 mg BD as side stream smoke, and smoky indoor air environments typically contain 10-20 |i.g/m 3 BD (Lofroth et ai, 1989) . Low exposure to BD is thus a common characteristic of the whole human population.
BD is a high priority compound for risk assessment, not only because of widespread exposure, but also due to its known toxicological properties. Several recent reviews have discussed the toxicological risks of 1,3-butadiene (e.g. Jacobson- Kram and Rosenthal, 1995; Sorsa and Peltonen, 1994) . BD is a multiple organ carcinogen in mice and rats, mice being by far the more sensitive species (Melnick and Huff, 1993) . Epidemiological studies in the BD industries have revealed associations between occupational exposure to BD and increased risk of haematopoietic cancers (see review by Landrigan, 1993) , although the overall classification by the I ARC (1992) placed BD in category 2 A, probably carcinogenic to humans. Very recently completed updates of US cohorts in BD production plants (Ward et ai, 1995) and in the styrenebutadiene rubber industry (Cole, 1995) showed significantly increased mortality from lymphohaematopoietic cancers, thus upgrading BD to a human carcinogen.
In its risk assessment excercise on ambient air pollutants the US Environmental Protection Agency has estimated (US EPA, 1990) BD to be the single most important air contaminant for lung cancer risk, being second only to products of incomplete combustion (PIC).
The European Community, in the priority setting programme on existing chemicals, has developed a computerized evaluation system allowing priority scoring for each chemical (JRC, 1994) . The priority score for BD is in the highest category, thus speeding up its risk assessment process. The results of this CEC/DGXII STEP funded project provide material for this process.
Materials and methods

Air monitoring of BD
To test the sample collection methods standard atmospheres with varying concentrations of BD were generated in a stainless steel dynamic 1 nr exposure chamber. The chamber air exchange rate was six times per hour and short-term deviations from nominal concentrations were <5%.
In quantitative analysis of BD in the samples the most critical step is the preparation of standards. We developed a new method for making standard preparations using a range of stock solutions. Stock solutions containing high concentrations of BD cannot be stored longer than overnight in a refrigerator, due to loss of BD from the solutions. This is caused by dimerization of BD to vinylcyclohexene and through evaporation. However, when dilutions are made die standard solutions can be stored for 2 weeks in a refrigerator without a detectable change in concentration
The air samples were analysed using a gas chromatograph equipped with a flame ionization detector (HP 5890; Hewlett Packard, CA). The detector and injector temperatures were 280 and 200°C respectively. Air and hydrogen flows were set to 280 and 30 ml/min. The helium make-up gas flow rate was 30 ml/min. The samples (1 u.1) were introduced using splitless injection (splitless time 0.5 min). Both autosampler and manual injection were used.
For active sampling of ambient air BD we used charcoal tubes from SKC (type 226-01) having front and rear sections of 100 and 50 mg respectively (SKC Ltd, Wimbome, UK). The flow rate in active sampling was set to 500 ml/min and was confirmed before and after sample collection.
In work site monitoring we used passive monitors of 3M type 3520, having a back-up section (3M, St Paul, MN). A diffusion rate of 42 8 ml/min was used in calculations. The flow rate in active sampling was set to 50 ml/min and was confirmed before and after sample collection. The samples were collected during the winter season when the temperature range was -4 to -13°C, during the summer season with the temperature range 15-25°C and during the fall with the temperature range 4-10°C.
Adducts
Haemoglobin adducts. In principle, similar methods were used both in the animal experiments (method A below) and for human biomonitoring (method B below). Two reactive metabolites presumably formed in vivo, 1,2-epoxy-3-butene (BMO) and diepoxybutane (BDE), were reacted with globin in vitro and formation of the expected valine adducts was demonstrated by gas chromatography/mass spectrometry (GC/MS), with modified Edman degradation (TOrnqvist et al., 1986) applied. Traces of the adduct formed by BDE could be demonstrated in rats after i.p. injection of this substance, but the method appeared not to be sensitive enough for biomonitoring purposes and was not developed further. Preliminary experiments showed that administration of BD to rats yielded the adduct expected from reaction of butadiene monoepoxide with the JV-terminal valine of globin and a procedure for its analysis was worked out Method A. The prerequisite for the analysis of globin adducts is the introduction of a suitable internal standard. It was decided to use the adduct resulting from reaction of 1,2-epoxybutane with the tripeptide Val-Gly-Gly. JV-(2-Hydroxybutyl)-Val-Gly-Gry was synthesized and characterized. A linear calibration curve was obtained with 15-100 pmol added to 50 mg globin with modified Edman degradation applied.
Erythrocytes were separated from heparinized blood samples by centrifugation (3000 r.p.m.) and washed three times with 0.9 % sodium chloride. Erythrocytes were then lysed by adding 4 vol. EDTA solution (0.1 mM, pH 7.4) and the lysate was dialysed against water. The hemolysate (6 ml) was poured into an ice cold solution of 0.2% HC1 in acetone, the mixture stirred for 15 min and centrifuged. The precipitated globin was washed with ethanol/ water (8:2), ethanol, ethanol/ether (1:3) and ether, dried in a desiccator and stored at -20°C.
Fifty milligrams of globin were dissolved in 1.5 ml formamide containing 7 u.1 pyridine by vortexing for 1 h together with internal standard (100 pmol in 100 uJ formamide). Then 10 u.1 pentafluorophenyl isothiocyanate (PFPiTC) were added and the mixture vortexed overnight at room temperature. After warming to 45°C for 90 min, 3 ml water were added and the supernatant, after centrifiigation, was applied to solid phase extraction columns (100 mg Adsorbcx RP-18; Merck, Darmstadt, Germany). Before loading, the columns were conditioned with 4 ml ethyl acetate, 4 ml methanol, 4 ml water and 1 ml heptane and after loading, the columns were washed with 4 ml water and I ml heptane. The adducts were eluted with 4 ml ethyl acetate. The solution was concentrated in a vacuum centrifuge and the residue dissolved in 1.5 ml toluene. The toluene solution was washed with 1 ml sodium bicarbonate (0.1 M), 1 ml water and concentrated again in a vacuum centrifuge. The residue was dissolved in 15-50 uJ toluene for GC/MS (Albrecht et al., 1993) . Since the standard is structurally not exactly identical with the test chemical an additional response factor, F = 1.34, was established. Under the applied conditions the two regioisomers, but not the diastereomers, were resolved. The area under the two peaks was used to calculate adduct levels.
Method B. Erythrocytes were separated from heparinized blood samples by centrifugation and were washed three times with 0.9% sodium chloride. The erythrocytes were then lysed in equal amounts of distilled water and the globin isolated essentially as described by Mowrer et al. (1986) .
For derivatization 200-300 mg aliquots of globin were dissolved in formamide (50 mg/1.5 ml). The internal standard (1-3 mg globin containing 8.75 pmol 2-hydroxypropylvaline/mg) was added to each sample. NaOH (1 M 40 uJ/50 mg globin) and PFPITC (10 uJ/50 mg globin) were added and derivatization was carried out essentially as described by Tomqvist et aL (1986) and Osterman-Golkar et al. (1991) . The tubes were tilted at room temperature overnight and then at 45°C for 2 h. The samples were then extracted three times with 6 ml diethyl ether. The ether extracts were combined and evaporated under nitrogen. The samples were dissolved in 1.5 ml toluene and washed twice with water, twice with freshly prepared 0.1 M sodium carbonate and twice again with water The toluene phase was evaporated to dryness under nitrogen. The samples were then reconstituted in 50 u.1 toluene and stored at -20°C until analyses were conducted.
A tripeptide (Val-Gly-Gly ethyl ester) containing radiolabelled valine was prepared from valine (7 nCi/mmol) and glycylglycine ethyl ester. The tripeptide was reacted with BMO and the adduct content determined by derivatization, as described for globin samples (below), and determination of the radioactivity of the PFPTH derivative. Calibration samples were prepared by adding various amounts (0.01-5 pmol) of the alkylated tripeptide and the internal standard to 200 mg samples of control globin. The MS/MS analyses were carried out using a Finnigan TSQ-700 instrument in the negative ion chemical ionization mode. The quantifications were based on measurement of peak areas for the fragment mJz 318; daughter fragment of both mlz 7>1A of the analyte and mil 362 of the internal standard (for details, see Osterman-Golkar et al., 1995) .
DNA adducts. Guanosine was reacted with racemic BMO [molar ratio 1:659 in a solution of 10 mM Tris-HCl, pH 7.2, and methanol (1:1 v/v)] for 6 days at 37°C by gentle mixing. Samples were withdrawn at 1 day intervals, the unreacted BMO was extracted twice with ether and the remaining aqueous layer was then subjected to hydrolysis for 1 h in the presence of 200 u.1 I N HCI. The hydrolysed mixture was then neutralized, filtered and analysed by HPLC (Neagu et al., 1995) .
Deoxyadenosine (dAdo) (1.5 g) was dissolved in trifluoroethanol (20 ml) and triethylamine acetic acid (1 ml) was added. BMO (300 u.1) was added and the reaction mixture was kept at 50°C for 7 days. After the reaction the sample was evaporated to dryness and dissolved in 20% methanol for HPLC analysis. Deoxyadenosine 3'-monophosphate (3'-dAMP) (2 mg/ml) was dissolved in 100 mM ammonium carbonate, pH 10.5, with daily BMO increments (10 u.l/mg) over ' week. After reaction, BMO was evaporated under nitrogen flow and the pH adjusted to 7.0.
Semipreparative separation of the reaction mixtures was accomplished using a 1.5 ml injection volume on an Ultrasphere (Altex, USA) 5 um ODS reverse phase semipreparative column (25 cmXIO mm). The mobile phase was 4% acetonitrile in water and the flow rate was 3 ml/min.
The isolated guanine products were analysed to determine the purity of peaks using a Shimadzu SPD-6A UV spectrophotometric detector working at 284 nm, a 3 cm guard column packed with Nucleosil C18 (Duren, Germany) and a Supelcosil LC-18 (Supelco Inc.) reverse phase analytical column (25X4.6 cm) The mobile phase was 8% acetonitrile in water at a flow rate of 1 ml/min. The 3'-dAMP products were purified using SAX Bond Elut (1 cc), allowing the analytes to be retained in the column, which was then washed with 1 ml 50 mM ammonium formate, pH 7.0. The analytes were eluted with 200 mM ammonium formate, pH 4.0. The sample was fractioned by HPLC using a gradient programme. Fractions were collected from 10 subsequent HPLC runs, pooled and the purity confirmed by analytical HPLC. For identification 3'-monosphosphate adducts were treated with alkaline phosphatase and the HPLC retention times were compared with the retention times of dAdo adducts. The 3'-dAMP products were further characterized using the MS/MS technique.
NMR spectra were obtained in 99.9% DMSO-d6 at 200 MHz, using a Varian Gemini 200 spectrometer. Electron impact mass spectra were measured by a Finnigan MAT 95 high resolution mass spectrometer using a direct insertion probe. The source temperature was kept at 210°C and the ionization voltage was 70 eV. Approximately 1 Jig of material was added to die probe and gradually heated until spectra were obtained. The chemical ionization spectra were recorded using isobutane.
UV spectra were recorded on a DU 64 Beckman (Beckman Instruments Inc., CA) UV/VIS spectrophotometer. Dried samples were diluted in water as necessary to obtain absorbance maxima between 0.5 and 1.0 OD.
Circular dichroism spectra were recorded on a Jasco 720 spectropolarimeter. The CD spectra were normalized by dividing each spectrum by the UV absorbance at Xm^-IR spectra were obtained on a Nicolet (Madison, WI) model 20 SXC FT1R spectrophotometer. Samples were analysed as potassium bromide tablets.
P-Postlabelling analyses.
Postlabelling of the modified dAdo was conducted as described in the literature (Koivisto et al., 1995) . The exact labelling efficiency was not determined, but was estimated to be -20%. The adducted deoxyadenosine 3',5'-diphosphate (dADP) was digested to adducted 5'-dAMP by nuclease PI treatment to facilitate the TLC separation. The reason for rejection of a traditional two-dimensional TLC in the final analysis of postlabelled samples is that some products, probably from endogenous sources, have very similar elution characteristics to the BMO A^-alkylated 3'-dAMP. The use of HPLC with a radioactivity detector is a combination able to overcome this problem. The sensitivity of the assay is now between 200 and 500 amol, depending on the amount of DNA used in the analysis.
DNA from rat and mouse liver and lung samples were isolated using standard phenol extraction and subsequently digested to 3'-nucleotides. The amount of DNA was determined by HPLC by quantifying the amount of 3'-dAMP. The adducts were enriched by HPLC and a fraction at the retention Ume of A*-alkyl 3'-dAMP was collected and postlabelled. The postlabelled samples were first purified by ion exhange TLC and the final analysis was based on HPLC with a radioactivity detector.
Cytogenetic methods
Micmnuclei in erythrocytes of rats and mice. Micronuclei (MN) were investigated using two target cell types, peripheral blood erythrocytes and femoral marrow erythrocytes.
Peripheral blood MN test. Smear preparations (mouse) were made directly after killing of the animals. The slides were fixed with methanol for 5 min and stained with conventional acridine orange (AO) according to Hayashi et at (1983) . AO supravital staining preparations (Hayashi et al., 1990) were made from rat blood. Briefly, 5 nl blood was placed on an AO-coated glass slide and covered immediately. These slides were examined by fluorescence microscopy within a few days. Reticulocytes with a red fluorescent reticulum in the cytoplasm were observed, and the incidence of MN in 1000 reticulocytes were scored per rat.
Bone marrow MN test. Femoral marrow cells were flushed out with fetal calf serum and a homogeneous cell suspension was obtained by pipetting. These cells were smeared onto clean slides, fixed with methanol for 5 min and stained by the conventional AO staining method or with May-Grilnwald Giemsa. The number of micronucleated polychromatic erythrocytes (MNPCEs) per 1000 polychromatic erythrocytes (PCEs) and PCEs per 1000 erythrocytes were scored for each rat and MNPCEs per 2000 PCEs for each mouse (Autio et al., 1994) .
Cytogenetic analyses in workers. Both chromosome aberrations (CA), sister chromatid exchanges (SCE) and MN in binucleated lymphocytes were analysed in workers exposed to BD and in referents employed at the same factory but not exposed to BD. Whole-blood lymphocyte cultures were set up in Falcon 3033 cell culture tubes (Becton Dickinson Labware, Lincoln Park, NJ), each culture containing 0.25 ml whole blood and 5 ml RPMI 1640 medium (Gibco, Glasgow, UK) supplemented with 15% fetal calf serum (Gibco), 1% Lglutamine (Orion Diagnostica, Espoo, Finland), 1% penicillin/streptomycin solution (100 U/ml penicillin and 100 Hg/ml streptomycin; Gibco), 1% phytohemagglutinin (Wellcome, Dartford, UK) and (for SCE cultures only) 0.5% 5 bromodeoxyuridine solution (1 mg/ml, final concentration 5 ng/ml; Calbiochem, La Jolla, CA). Triplicate cultures per person were set up for each end point. Forty hours after initiation 60 ul cytochalasin B solution (final concentration 6 u.g/ml; Sigma, St Louis, MO) was added to cultures for the MN assay. The cultures were incubated, caps closed, at 37°C for 48 (chromosomal aberrations), 66 (MN) or 68 h (SCE). Two and a half hours before harvesting 70 nl colcemid solution (10 (ig/ml; Gibco) was added to the cultures for chromosomal aberrations and SCEs. The cells were treated with a hypotonic solution of KC1 (0.075 M) for 8 or 2-3 min (MN series), a 1:1 mixture of RPMI 1640 medium and distilled water. The cells were then fixed three times with methanol/acetic acid (3:1, both p.a. grade; Merck, Darmstadt, Germany). The triplicate cultures of each sample and end point were united after the second fixation. Microscope slides were prepared on wet or dry (MN series) glass slides by air drying and stained with either Giemsa (chromosomal aberrations) or fluorescence Giemsa (SCEs). The MN slides were stained with May-Grtlnwald Giemsa. Differences between groups were determined with Student's two-tailed (-test. The dose-response relationship was determined by linear regression analysis.
For chromosomal aberrations 200 (Plant A, Sines study) and 300 metaphases (Plant B, Kralupy I and II studies) were analysed and 50 second division metaphases per donor were analysed for SCEs. For the MN analyses 1000 binucleate cells per person were studied. The slides were coded so that the analyst was not aware of the exposure status.
Oncoprolein analyses
Samples of plasma from workers exposed respectively to BD or to BD + styrene from a factory in Kralupy, near Prague (Plant B, Study I) were screened for the presence of Ras oncoproteins using an immunoconcentration technique based on the method described in Brinkworth et al. (1992) and direct analysis of the plasma without immunoconcentration.
Ten millilitres of heparinized blood samples (40 U/ml) were collected from workers at the same time as the other samplings from Plant B (sampling I); 10 samples from BD monomer production and 13 samples from BD + styrene polymer production workers. The samples from 15 people who had had no contact to these chemicals were negative controls. The samples were centrifuged at 170 g for 5 min and the plasma removed. Aliquots of 1.5 ml were transferred to a 7 ml Bijou tube containing protease inhibitors, 65 ^1 0.5 M aqueous iodoacetamide and 26 JJ.1 0.1 M phenylmethylsulphonyl fluoride (PMSF) in isopropanol. Five millilitres of 20% sodium dodecylsulphate (SDS) were added and the mixture dispensed into 1.5 ml aliquots and stored frozen at -70°C until required.
The samples were thawed at 37°C and chilled to precipitate the SDS, which was pelleted by centrifugation at 489 g at 4°C for 10 min. Ras proteins in the plasma samples were analysed with or without immunoconcentration (Anderson et al, 1995) .
The P21 proteins were measured densitometrically using a light densitometer (BioRad Model 620 Video Densitometer). Optical densities of protein bands were recorded as peak areas at 21 kDa, which is assumed to represent the ras oncogene product, and the mean ± SD of the negative control samples were calculated. Values for samples from the exposed people in the present study were considered raised if >2 SD above the mean observed for the relevant group of negative controls.
Optical densities were also measured at 35 kDa, the latter representing a protein band found in each sample of plasma and considered as a standard band for comparison with the P21 bands. This comparison was used as a means of standardizing one gel lane with another, with the comparison band being a plasma protein which was considered the same in all lanes. The method of Perera el al. (1992) was used to compare control and exposed samples.
Animal inhalation exposures
Exposure of rats. This study was performed using Wistar rats (Autio et al., 1994) . The animals were exposed to BD in open inhalation chambers controlled for constant concentration of the gas with a Miran spectrophotometer. The concentrations used were 0, 50, 200 and 500 p.p.m., 6 h/day for 5 consecutive days, 10 animals/group. The animals were killed 1 day after the last exposure and blood was taken by heart puncture.
Exposure of mice. Twenty CB6 Fl mice per exposure concentration (0, 50, 200, 500 and 1300 p.p.m.) were exposed at a time for 6 h/day on 5 consecutive days. Blood was taken by cutting the vena cava under diethyl ether anaesthesia 18 h after the final exposure (Autio et al., 1994) .
Human studies
Altogether blood samples from 106 persons were studied from three different factories or units of plants: 17 exposed (and 10 controls) from a BD manufacturing plant in Sines, Portugal (Plant A); 23 exposed (and 20 controls) in a styrene-butadiene polymerization and manufacturing unit in Kralupy, Czech Republic (Plant B, sampling I); 16 workers (and 20 controls) in a processing plant in Kralupy, Czech Republic (Plant B, sampling II). At the time of blood sampling personal and stationary monitoring of air levels of BD were also conducted .
Results
BD in urban air
The urban air samples were collected from March to May 1994 at the intersection of four different streets in the city of Helsinki. The samples were collected mainly during rush hours in the morning and the afternoon. The mean concentration of BD in the samples was 0.3 p.p.b. (SD ± 0.29, SE ± 0.036, n = 74). The highest and lowest concentrations of BD detected were 2.9 and 0.1 p.p.b. respectively. The low level of 1,3-butadiene detected in this study is a typical value for urban areas (IARC, 1992) .
The BD concentration was analysed in two types of fresh petrol samples (95 and 98 octane unleaded) taken from four different Finnish petrol stations (Kesoil, Esso, Shell and Neste). None of the petrol samples analysed showed detectable amounts of BD. The detection limit of the assay applied was 0.5 (ig/ml BD, corresponding to a level of 0.005% (w/w) in petrol.
Ten full-shift personal samples (passive monitors) were collected from ten Spanish petrol filling station attendants in Barcelona, Spain. The samples revealed only a very low exposure to BD (mean 0.015, SD ± 0.014, SE ± 0.004 p.p.m.). The highest and lowest amounts of BD detected were 0.05 and 0 p.p.m. respectively. This very low exposure of the filling station attendants is most probably due to the presence of BD in automobile exhausts, rather than BD in petrol. However, the BD concentration in Spanish petrol was not determined in this study.
BD in the process industry
Both active and passive sampling methods were field tested in three different petrochemical plants (Figure 1 ). They showed excellent correlation (r = 0.99) (Peltonen and Vaaranrinta, 1995) . Four samplings were performed at three different BD manufacturing plants (Plant A, Sines, Plant B, Kralupy II and Plant C, Porvoo) and two polymerization plants (Plant B, Kralupy I and Plant D, Veitsiluoto). The ambient levels in these operations varied greatly, but the lowest BD levels in area samples were detected in the manufacturing process industry in Plant C (70% of samples <0.2 p.p.m.). Slightly higher values were measured in Plant A (60% of samples <2 p.p.m.). The highest area concentrations of BD were detected in Plant B (sampling I), where almost 45% of the area samples exceeded 10 p.p.m. (Figure 2 ). The full-shift personal monitoring samples from the breathing zone area of the workers taking part in the study showed 70% of the samples to be <0.2 p.p.m. in Plant A and the BD manufacturing plant in Plant C (Ahlberg et al., 1992) . In Plant B the concentrations of BD in personal samples were fairly similar in both samplings (I and II). The typical range measured was between 0.2 and 2.0 p.p.m. (-50% of samples). About 10% of the samples exceeded 10 p.p.m. However, some very high exposures were detected (>500 p.p.m.) at both sampling times. The results are summarized in Figure 3 . The main exposure source of BD in styrene-butadiene polymerization units are leaks from large containers and, because they are indoors, the exposure levels may be higher than in BD manufacturing. The main exposure level was between 5 and 10 p.p.m. and almost 40% of the samples exceeded 10 p.p.m. The results are shown in Figure 4 for Plant B, sampling II, and Plant D, a recently renovated plant in Finland.
The chemistry of DNA adducts
The /V7-alkylated guanines were prepared by reacting guanosine with BMO in glacial acetic acid and the products formed were isolated by HPLC. The purity of the fractions was determined on an analytical column and was >95% for each of the fractions. The products were formed at a molar ratio of 1.1:1.0 with 8% yield.
The UV spectra of the two isomers resemble those of A7-alkylguanine. A shoulder was observed at 245 nm (e = 6600) and the main absorption occurs at 284 nm (e = 8030). A typical shift towards shorter wavelengths of the main absorption was also observed at low pH with these products.
The mass spectral information confirms that each guanine had trapped one molecule of BMO. The molecular ion M+221 is present in both El spectra and in chemical ionization spectra M+l (pilz 222, base peak) and M+57 (mlz 279) were also detected.
In the IR spectra of the products there was a strong and broad absorbance band in the region 3200-3400/cm. This is not present in spectra of unsubstituted guanine. Absorption in this region is usually associated with the presence of hydroxyl groups. Compound I has a strong and broad absorbance maximum at 3432/cm, indicative of a hydrogen bonded secondary alcohol group, and compound II has a strong and broad absorption maximum at 3404/cm, indicative of a hydrogen bonded primary alcohol group.
The data from the I3 C and 'H NMR experiments confirm the final structural interpretation of these two products. The greatest differences between the spectra of the synthesized standards and guanosine are associated with the C5 and C8 atoms and is consistent with yV7-alkylation. Further, a shielding effect on the ortho C5 carbon of compound I (which occurs 6.90 p.p.m. upfield from that in guanosine) generally occurs upon alkylation of heterocyclic nitrogen atoms.
After summarizing all the spectroscopic data we came to the conclusion that the first eluting compound was the product in which a covalent bond formed between the terminal carbon of BMO and the N7 position of guanine, while the second compound was identified as a product in which a bond formed between carbon C2 of BMO and N7 of guanine. The structure of the adduct is thus confirmed as similar to that suggested by Citti et al. (1984) .
Depurination by neutral thermal hydrolysis was used to estimate the total amount of modification at the N7 position of deoxyguanine in DNA. The time needed for complete release of the two adducts was determined to be 30 min. Samples examined after that time showed no further increase in the two peaks. Adduct formation in Ct DNA as a function of time is shown in Figure 5 .
The A^-alkyldeoxyadenosines were prepared by reacting dAdo with BMO in trifiuoroethanol under alkaline conditions. HPLC analysis of a reaction mixture of racemic BMO and dAdo showed the formation of three products. Further analysis using different elution compositions did not reveal more products (the expectation was four products). HPLC analyses of the reaction mixtures of dAdo and the R or the 5 enantiomers of BMO showed the formation of two peaks. The relative intensity of these two peaks were 1:2 in both reaction mixtures. The experiments with pure enantiomers showed that the elution order is peak I from R-BMO and peak II from 5-BMO, with peak HI a mixture of both enantiomers.
Mass spectral studies of the products showed that all of them had trapped one BMO molecule. The positive FAB showed a mlz 322 ion as the base peak and only minor fragmentation of the molecule is observed. The intensity of the mlz 206 ion was less in products I and II and ion mlz 136 is more intense in the mass spectrum of fraction three. The Exposure [ppm] 1H NMR spectra of products I and HI both had a broad signal at 7.9 p.p.m. with an integral of one proton. This was assigned to the alkylated exocyclic amino group of dAdo. A clear sign of a C-C double bond from BMO was recorded as an octet at 6.2 p.p.m. After summarizing all the spectroscopic data we came to the conclusion that the modification site in dAdo under the conditions applied in this study is the exocyclic amino group of dAdo and that the products formed are the two regioisomers.
HPLC analysis of the reaction mixture of BMO and 3'-dAMP showed two products. The isolated 3'-dAMP products were treated with alkaline phosphatase, after which an HPLC analysis showed similar retention times to the positively identified dAdo markers. The conformity of the 3' products were further assured using MS/MS. This was done using the mlz 206 ion, which represents the BMO-modified base. This experiment showed that the collision-activated spectra of modified dAdo and modified 3'-dAMP were identical.
Animal studies Haemoglobin adducts.
A clear dose-dependent increase in adduct levels was observed in both rats and mice, but the levels were approximately five times higher in mice than in rats. At the 1300 p.p.m. exposure level the adduct levels were 5 and 27.4 nmol/g globin and at 500 p.p.m. they were 3.5 and 17 nmol/g globin in rats and mice respectively (Albrecht et al, 1993) .
hi a second experiment (Adler et al., 1994) two male and two female C3HX101/EL mice per concentration were exposed. Female mice from two different strains did not show a significant difference in adduct levels, neither did female and male animals from the C3HX101/EL strain at any of the exposure concentrations between 50 and 1300 p.p.m. The results of the animal experiments revealed sufficient sensitivity and reproducibility of the analytical method. DNA adducts. M-Alkyldeoxyadenosine adducts of BMO were detected in both rats and mice. The number of N 6 adducts in liver DNA per normal 3'-dAMP (fmol/100 nmol) as a function of BD exposure was shown to be linear ( Figure 6 ). The results demonstrate for the first time, in a dose-response manner, specific DNA adducts formed after in vivo inhalation exposure to BD.
The results on adduct levels in the lung samples of rats and mice are shown in Figure 7 . The adduct levels detected in lung samples of mice were slightly higher than the adduct levels detected in rat lung. However, the adduct levels in lung samples in both species were clearly lower than the adduct levels in the liver samples of rats at the same exposure level.
Micronuclei. In male Wistar rats no dose-related effects on MN frequencies were observed either in peripheral blood erythrocytes or in bone marrow cells at inhalation exposure levels of 50, 200 and 500 p.p.m. BD.
However, a clear dose-dependent increase in the frequencies of MN was observed in mice in both blood and bone marrow cells (Figure 8 ). Mice exhibited positive responses in both tissues at the lowest concentration (50 p.p.m.) tested (see Autio et aL, 1994, for details) .
Human biomonitoring
The biomarkers measured in the samples were haemoglobin adducts and cytogenetic end points (CAs, SCEs and MN) in peripheral lymphocytes in three different samplings from two plants.
Haemoglobin adducts. The adduct levels seen in the workers of Plant A and a few workers from Plant B are given in Table  I . The results are in agreement with a previous study in Texas (Osterman-Golkar et aL, 1993) , where the exposure levels were approximately the same as in Plant A (Sines) (< 1 p.p.m.). The ambient measurements in Plant B (Kralupy) clearly showed that the exposure levels during the first study (I) were higher (>3 p.p.m.) than during the second study (II) (<3 p.p.m.). In accordance with this, workers in Plant B showed higher haemoglobin adduct levels than workers in Plant A and higher levels in the first study of Plant B than in the second, according to the preliminary results. No significant differencies were found between smokers and non-smokers in the groups (see details in Osterman-Golkar et aL, 1995) . Cytogenetic biomonitoring. No BD exposure-related effects were seen in any of the populations studied or in any of the cytogenetic parametres (Table II ) (see Sorsa et aL, 1994, for details) . Some high individual values in multi-aberrant cells were seen in Plant B, sampling II, but their significance in relation to BD exposure is not known.
Significant correlation with smoking and SCE, as well as CA, was seen among the study population, while age correlated significantly with the frequency of MN . Ras oncoproteins. It has been suggested that the detection of activated oncogenes may play a major role in the evaluation of cancer hazard in populations exposed to carcinogens in the work place (Brandt-Rauf, 1988 ). An elevation of Ras (p21) oncoprotein levels in adult humans has been shown to correlate with prior exposure to hazardous chemicals (Brandt-Rauf, 1991 (1992) reported a doubling in frequency of high ras oncogene expression in people exposed to environmental pollution in Poland.
Plasma samples from 10 male workers in Plant B, sampling I, occupationally exposed to BD and 13 exposed to BD + styrene were compared with negative male controls, roughly matched for age and smoking habits, for the presence of Ras oncoproteins as possible biomarkers in their plasma. Proteins were separated by gel electrophoresis, transferred to a nitrocellulose membrane by Western blotting and detected by chemiluminescence, using monoclonal anti-Ras antibody as the primary antibody. There were no statistically significant differences between the three groups (pooled two sample Mest, untransformed and non-parametric Mann-Whitney test; Table III ). Discussion BD is a high priority compound for risk assessment, not only because of its wide exposure, but also considering its known toxicological properties. BD requires metabolic activation to reactive epoxides in order to bind to DNA and initiate events leading to mutation and cancer. Species differences in metabolism, including both activation and detoxification, are therefore very relevant to its toxic manifestations and for risk assessment. BD is practically non-toxic acutely, but is a multiple organ carcinogen in mice and rats, the mouse being the far more sensitive species. The species differences in response to BD relate to several genetic and metabolic characteristics (Bond et al, 1993) . Physiological parameters, such as ventilation rate and cardiac output, may also be important in determining the species differencies (Kohn and Melnick, 1993) .
This species difference was also seen in the present study. Mice were found to be more sensitive than rats in inhalation studies with BD; the same exposure level and regimen gave no MN in rat bone marrow PCEs or in peripheral blood erythrocytes, while in mice a positive linear dose-response relationship was obtained at the lowest exposure level used (50 p.p.m., 6 h/day, 5 days/week for 2 weeks) (Autio et al., 1994) . A dose-dependent increase in haemoglobin adduct levels was seen in both rats and mice, but on average the •"Samples giving results > mean + 2 SD of the negative control group. c Samples giving results > mean + 2 SD of the negative control group without sample 59. levels were about five times higher in mice than in the rat (Albrecht et al., 1993) .
The differences between the two rodent species may derive from various biological causes. In 'nose only' experiments mice show five times higher uptake of inhaled BD than rats or cynomolgus monkeys (Henderson et al., 1993) . Furthermore, metabolic differencies in both oxidation of BD and in conjugation with glutathione suggest that the mouse is the most vulnerable species to the genotoxic effects of BD (Bond et al., 1993) .
A specific 32 P-postlabelling method was developed to analyse BMO-induced DNA adducts at the N 6 position of alkyldeoxyadenosine (Koivisto et al., 1995; Neagu et al., 1995) . A dose-response relation of DNA adducts to BD concentration was seen in both the rat liver and lung, as well as in mouse lung DNA samples. This is the first demonstration of BD-induced specific DNA adducts in rats and will be reported separately (Koivisto et al., 19%) . When the lung DNA samples from mice and rats were compared the adduct levels were slightly higher in mice than in rats. The DNA adduct levels in rat lung were one order of magnitude lower than in rat liver.
Occupational exposure to BD is highest in the chemical production industry (Fajen et al, 1993) . Measurements performed within this project indicated exposure levels mainly <1 p.p.m. (2.2 mg/mA) and seldom exceeding 3 p.p.m. (6.7 mg/nr) in three European BD production facilities. However, high peak exposures may occur during repair, maintenance, cylinder sampling and bomb voiding. Short-term exposures were measured as exceeding 10 and even 100 p.p.m.
Although the environmental levels of BD are several orders of magnitude lower, in the p.p.b. range, BD is a compound to which everybody is exposed, occurring in tobacco smoke, automobile exhaust and fire emissions. Within this project city air BD levels were measured within the range 0.1-2.9 p.p.b. Slightly higher levels were measured in a petrol station (5-50 p.p.b.) . This is obviously due to the more intense automobile exhausts, since various brands of petrol analysed showed no measurable amounts of BD.
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Human biomonitoring studies were concentrated on occupational environments where BD exposure levels are three to five orders of magnitude higher than in the general environment. Studies of blood protein adducts showed increased levels (0.16 ±0.1 pmol/g) in process workers engaged in BD sampling and voiding, as compared with the levels in maintenance and laboratory workers and those in controls (0.1 and 0.13 pmol/ g respectively) in Plant A. The particular adduct measured was 2-hydroxy-3-butenyl valine, formed by reaction of the N-terminal valine of haemoglobin with Cl in BMO (OstermanGolkar et al., 1995) .
These results are concordant with an earlier study on haemoglobin adduct levels in workers at a US chemical production plant where BD exposure levels were roughly at the same level, mostly <1 p.p.m. (Osterman-Golkar et al., 1993) . In Plant B, where exposure levels were increased due to annual maintenance of the plant (sampling I), the adduct levels were much higher, with high inter-individual variation (2.0 ± 3.6 pmol/g in sampling I and 0.54 ± 0.33 pmol/g in sampling II) also. However, no clear correlation between ambient BD level from personal monitoring and adduct level was seen. This points to the general problem of comparing acute exposure level measurements with biologically effective dose measurements showing accumulation of the biological parameter analysed.
The BMO adduct levels observed in BD-exposed workers are considerably (one to two orders of magnitude) lower than those in rats and mice if extrapolated for the same ambient exposure. Although indicative of an overall lower efficiency of BD in humans, risk estimation would require studies on the relative importance of other reactive BD metabolites. Further studies are also required to determine the background levels and to evaluate the impact of smoking and possible genetic susceptibilities as a cause of variation in adduct levels.
In contrast to the haemoglobin adduct measurements, the cytogenetic parameters studied (CA, SCE and MN) showed no exposure-related increase in any of the three sub-studies performed. As observed earlier in several cytogenetic biomonitoring studies, smoking, as well as ageing, however, had an influence on the end points studied. Smokers had significantly higher (P < 0.01) mean SCE than non-smokers. Age increased the frequency of MN (P < 0.001) and had a weaker effect on CA frequency (P < 0.05). However, ambient BD level from personal monitoring was a non-significant determinant for all of the three end points in a multifactorial regression analysis . No statistically significant exposurerelated increase in chromosome aberrations was seen in another worker population with BD exposure, although a trend for increased breaks was seen and the lymphocyte cells of workers after radiation challenge responded with an increased aberration rate (Au et al., 1995) .
Theoretically an increase in Ras protein levels in plasma can be considered to arise either from a large amount of Ras from a small number of cells (e.g. a tumour) or from many cells producing a small increase in Ras proteins. In the present study there were no statistically significant differences between the three groups (pooled two sample r-test, untransformed and non-parametric Mann-Whitney test) (Anderson et al., 1995) . These results are in keeping with the lack of exposure-related effects for the three cytogenetic end points in this occupational group exposed to low BD levels.
Considering the various biomarker end points used to monitor BD exposure in experimental animals and humans, both sensitivity and specificity need to be addressed. The cytogenetic end points, although quite sensitive in the mouse, lack the specificity to respond to the generally low BD exposures in the worker studies.
Measurement of adducts of BMO with the N-terminal valine of haemoglobin and with N 6 of adenine in DNA are both specific and sensitive. Methodological developments to further improve the enrichment of DNA adducts in the analysis are ongoing. In humans data is so far available only for haemoglobin adducts, but still on a limited number of persons. This finding is important in revealing that biologically effective doses of BD can be reached even at the present-day low level of industrial exposure.
